Lacey E. Dobrolecki
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Michael T. LewisRobert J. HickeyMiloš V. NovotnýYehia MechrefZuzana KyseľováMichael A. ManciniLinda H. MalkasLauren A. Schnaper
- Topics
- Cancer Cells and Metastasis (14 papers)Cancer Genomics and Diagnostics (7 papers)Glycosylation and Glycoproteins Research (6 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Lacey E. Dobrolecki
49 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Molecular Biology 1.4k
- Oncology 891
- Cancer Research 412
- Immunology 405
- Pulmonary and Respiratory Medicine 245
Countries citing papers authored by Lacey E. Dobrolecki
This map shows the geographic impact of Lacey E. Dobrolecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lacey E. Dobrolecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lacey E. Dobrolecki more than expected).
Fields of papers citing papers by Lacey E. Dobrolecki
This network shows the impact of papers produced by Lacey E. Dobrolecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lacey E. Dobrolecki. The network helps show where Lacey E. Dobrolecki may publish in the future.
Co-authorship network of co-authors of Lacey E. Dobrolecki
This figure shows the co-authorship network connecting the top 25 collaborators of Lacey E. Dobrolecki. A scholar is included among the top collaborators of Lacey E. Dobrolecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lacey E. Dobrolecki. Lacey E. Dobrolecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 4 | |
| 5 | 0 | |
| 6 | 9 | |
| 7 | 33 | |
| 8 | 18 | |
| 9 | 8 | |
| 10 | 5 | |
| 11 | 24 | |
| 12 | 16 | |
| 13 | 57 | |
| 14 | Mutual regulation of tumour vessel normalization and immunostimulatory reprogrammingbreakdown → | 596 |
| 15 | 49 | |
| 16 | Human C6orf211 Encodes Armt1, a Protein Carboxyl Methyltransferase that Targets PCNA and Is Linked to the DNA Damage Response | 1 |
| 17 | 137 | |
| 18 | 209 | |
| 19 | 27 | |
| 20 | 53 |
About Lacey E. Dobrolecki
Lacey E. Dobrolecki is a scholar working on Oncology, Cancer Research and Biotechnology, having authored 53 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (14 papers), Cancer Genomics and Diagnostics (7 papers) and Glycosylation and Glycoproteins Research (6 papers). The work is most often cited by research in Oncology (891 citations), Cancer Research (412 citations) and Molecular Biology (1.4k citations). Lacey E. Dobrolecki has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Michael T. Lewis, Robert J. Hickey, Miloš V. Novotný, Yehia Mechref, Zuzana Kyseľová, Michael A. Mancini, Linda H. Malkas, Lauren A. Schnaper, Xiaomei Zhang and Melissa D. Landis. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.